Pandemic H1N1 influenza vaccine (Serum Institute of India Ltd)

N/A

Report date: 2022/04/18 20:00:49

Base Information

Drug NamePandemic H1N1 influenza vaccine (Serum Institute of India Ltd)

Drug Alias NameLive-attenuated influenza virus vaccine H1N1LAIV influenza A vaccine H1N1 - SIIPandemic influenza A H1N1 - intranasalNasovac

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2010/07/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Experimental Medicine Of The Russian Academy Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeJ07BB03